Spire Healthcare Group Plc (SPI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Spire Healthcare Group Plc (SPI) has a cash flow conversion efficiency ratio of 0.151x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX112.50 Million ≈ $13.69K USD) by net assets (GBX743.70 Million ≈ $90.49K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Spire Healthcare Group Plc market capitalisation for the company's overall valuation and market capitalisation.
Spire Healthcare Group Plc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Spire Healthcare Group Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Spire Healthcare Group Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Spire Healthcare Group Plc ranked by their cash flow conversion efficiency. Explore Spire Healthcare Group Plc cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Weizmann Limited
NSE:WEIZMANIND
|
0.281x |
|
Aspire BioPharma, Inc.
NASDAQ:ASBP
|
-0.180x |
|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
-0.247x |
|
AIR INDUSTRIES GR.DL-001
F:YH1
|
-0.031x |
|
Phio Pharmaceuticals Corp
NASDAQ:PHIO
|
-0.243x |
|
Astute Metals NL
AU:ASE
|
-0.011x |
|
Boa Concept SA
PA:ALBOA
|
0.010x |
|
Intraco Penta Tbk
JK:INTA
|
-0.008x |
Annual Cash Flow Conversion Efficiency for Spire Healthcare Group Plc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Spire Healthcare Group Plc from 2011 to 2025. View SPI live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX743.70 Million ≈ $90.49K |
GBX219.30 Million ≈ $26.68K |
0.295x | -6.65% |
| 2024-12-31 | GBX746.20 Million ≈ $90.79K |
GBX235.70 Million ≈ $28.68K |
0.316x | +8.14% |
| 2023-12-31 | GBX737.80 Million ≈ $89.77K |
GBX215.50 Million ≈ $26.22K |
0.292x | +16.62% |
| 2022-12-31 | GBX725.10 Million ≈ $88.22K |
GBX181.60 Million ≈ $22.10K |
0.250x | +3.47% |
| 2021-12-31 | GBX704.80 Million ≈ $85.75K |
GBX170.60 Million ≈ $20.76K |
0.242x | +20.70% |
| 2020-12-31 | GBX706.60 Million ≈ $85.97K |
GBX141.70 Million ≈ $17.24K |
0.201x | -6.55% |
| 2019-12-31 | GBX939.90 Million ≈ $114.36K |
GBX201.70 Million ≈ $24.54K |
0.215x | +11.47% |
| 2018-12-31 | GBX948.50 Million ≈ $115.41K |
GBX182.60 Million ≈ $22.22K |
0.193x | +61.14% |
| 2017-12-31 | GBX1.04 Billion ≈ $126.28K |
GBX124.00 Million ≈ $15.09K |
0.119x | -30.28% |
| 2016-12-31 | GBX1.04 Billion ≈ $125.97K |
GBX177.40 Million ≈ $21.58K |
0.171x | +10.07% |
| 2015-12-31 | GBX997.60 Million ≈ $121.38K |
GBX155.30 Million ≈ $18.90K |
0.156x | +31.56% |
| 2014-12-31 | GBX955.00 Million ≈ $116.20K |
GBX113.00 Million ≈ $13.75K |
0.118x | +130.41% |
| 2013-12-31 | GBX-256.20 Million ≈ $-31.17K |
GBX99.70 Million ≈ $12.13K |
-0.389x | +2.76% |
| 2012-12-31 | GBX-441.80 Million ≈ $-53.75K |
GBX176.80 Million ≈ $21.51K |
-0.400x | +12.27% |
| 2011-12-31 | GBX-426.60 Million ≈ $-51.90K |
GBX194.60 Million ≈ $23.68K |
-0.456x | -- |
About Spire Healthcare Group Plc
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of o… Read more